Is your patient eligible?
The Oncomap test is for patients who have advanced, metastatic, refractory, relapsed, or recurrent cancer.
Guidance for sample submission
The Oncomap test can be run on samples as small as 3 mm2 with ≥15% tumor content, but larger samples ≥10 mm2) with higher tumor content (≥20%) are preferred, when available. For tissue blocks where the overall tumor content does not meet criteria, microdissection will be performed, if possible.
To reduce delays in testing and subsequent treatment, we recommend that a pathologist select the optimal block for testing. Please reference our sample submission guidelines and choose the FFPE block with the greatest amount/area of the highest-grade carcinoma, morphologically consistent with the submitting diagnosis. Ethylenediaminetetraacetic acid (EDTA) should be used for samples requiring decalcification to preserve nucleic acid and protein expression.
Download the Sample Submission Guidelines
Download the Bone Decalcification Instructions